Ropes & Gray LLP has an experienced and established team, which has a strong record across both issuer and underwriter representation. In a slow market, the firm has continued to demonstrate its excellence in IPOs, follow-on offerings, SPAC IPOs and de-SPAC transactions, and at-the-market offerings. It stands out for its expertise in representing private equity firms and their portfolio companies, along with biotech and pharmaceutical companies. New York partners Rachel Phillips, Faiza Rahman, Christopher Capuzzi and Paul Tropp are key names, along with Craig Marcus in Boston.
Legal 500 Editorial commentary
Key clients
- Hayward Holdings
- The Hillman Group
- Ecovyst Catalyst Technologies
- Ginkgo Bioworks
- ImmunoGen
- Lilium NV
- LSB Industries
- Rallybio Corporation
- Sarepta Therapeutics
- TransMedics
- Duckhorn
Work highlights
- Represented Hayward Holdings and CCMP Capital Advisors, a selling stockholder, in two secondary offerings of shares of Hayward’s common stock.
- Represented TransMedics Group in its follow-on underwritten public offering of 3.25m shares of common stock.
- Represented Ecovyst and its selling stockholder, CCMP Capital Advisors, in several equity transactions worth an aggregate of $579m.
Practice head
The lawyer(s) leading their teams.
Craig Marcus, Paul Tropp